Serum thymidine kinase levels are elevated and exhibit diurnal variations in patients with advanced ovarian cancer (Q74195016)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Serum thymidine kinase levels are elevated and exhibit diurnal variations in patients with advanced ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

M Hallek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F Lévi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Mechkouri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Bogdan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F Bailleul

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R Senekowitsch

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B Emmerich

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

155-166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

Serum thymidine kinase in vitamin B12 deficiency

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Serum thymidine kinase in acute leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Serum deoxythymidine kinase gives prognostic information in chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Serum thymidine kinase as a prognostic marker in Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Deoxythymidine-kinase in cerebrospinal fluid: A new potential ?marker? for brain tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Thymidine kinase in brain-tumor cysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Thymidine kinase in extracts of human brain tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Application of an in vitro assay for serum thymidine kinase: results on viral disease and malignancies in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Circadian CEA variability: when to sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

Serum deoxythymidine kinase correlates with peripheral lymphocyte thymidine uptake in chronic lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2897%2900132-0

10.1016/S0009-8981(97)00132-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9469250%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference